Beta-Blocker Use Is Associated With Impaired Left Atrial Function in Hypertension
Related Experiment Video
Updated: Mar 8, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Mayank Sardana1, Amer Ahmed Syed2, Zeba Hashmath2
1Cardiology Division, Department of Medicine, University of Massachusetts Medical School, Worcester, MA.
Insights
Beta-blocker use in hypertension impairs left atrial (LA) mechanical function, affecting reservoir, conduit, and booster pump functions. This finding may explain increased risks of atrial fibrillation and stroke associated with beta-blockers.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Pharmacology
Background:
- Impaired left atrial (LA) mechanical function is a known complication of hypertension.
- The impact of different antihypertensive drug classes on LA function remains largely unknown.
- LA dysfunction contributes to atrial arrhythmias, stroke, and heart failure.
Purpose of the Study:
- To investigate the association between antihypertensive medication use and LA mechanical function in hypertensive patients.
- To determine if specific antihypertensive drug classes differentially affect LA function.
Main Methods:
- Cardiac MRI with feature-tracking was used to assess LA strain in 212 hypertensive subjects.
- Multivariable regression models were employed to analyze associations, adjusting for relevant clinical and demographic factors.
- LA function was evaluated based on reservoir, conduit, and booster pump capacities.
Main Results:
- Beta-blocker use was significantly associated with impaired LA reservoir function (lower total longitudinal strain and expansion index).
- Conduit function was also impaired in beta-blocker users (lower positive strain and early diastolic strain rate).
- Booster pump function was reduced, indicated by lower late-diastolic strain/strain rate and active LA emptying fraction.
Conclusions:
- Beta-blocker therapy is linked to impaired left atrial mechanical function in hypertension.
- This association may contribute to the increased risk of atrial fibrillation and stroke observed with beta-blockers in recent studies.
- Other antihypertensive agents did not show a significant association with impaired LA function.
Background:
Impaired left atrial (LA) mechanical function is present in hypertension and likely contributes to various complications, including atrial arrhythmias, stroke, and heart failure. Various antihypertensive drug classes exert differential effects on central hemodynamics and left ventricular function. However, little is known about their effects on LA function.
Methods And Results:
We studied 212 subjects with hypertension and without heart failure or atrial fibrillation. LA strain was measured from cine steady-state free-precession cardiac MRI images using feature-tracking algorithms. In multivariable models adjusted for age, sex, race, body mass index, blood pressure, diabetes mellitus, LA volume, left ventricular mass, and left ventricular ejection fraction, beta-blocker use was associated with a lower total longitudinal strain (standardized β=-0.21; P=0.008), and lower LA expansion index (standardized β=-0.30; P<0.001), indicating impaired LA reservoir function. Beta-blocker use was also associated with a lower positive strain (standardized β=-0.19; P=0.012) and early diastolic strain rate (standardized β=0.15; P=0.039), indicating impaired LA conduit function. Finally, beta-blocker use was associated with a lower (less negative) late-diastolic strain (standardized β=0.15; P=0.049), strain rate (standardized β=0.18; P=0.019), and a lower active LA emptying fraction (standardized β=-0.27; P<0.001), indicating impaired booster pump function. Use of other antihypertensive agents was not associated with LA function.
Conclusions:
Beta-blocker use is significantly associated with impaired LA function in hypertension. This association could underlie the increased risk of atrial fibrillation and stroke seen with the use of beta-blockers (as opposed to other antihypertensive agents) demonstrated in recent trials.
Related Concept Videos
Heart Failure Drugs: β-Blockers
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Types of β-Blockers

